- CEO
- Gong Xing Xie
- Full Time Employees
- 1,066
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Shanghai China
- IPO Date
- Dec 16, 2021
- Business
- Mingyue Optical Lens Co., Ltd. is a China-based optical lens manufacturer engaged in the research, development, design, production, and distribution of optical resin lenses, raw lens materials, and related eyewear products. Founded in 2002 and tracing its manufacturing origins to 1997, the company is headquartered in Shanghai, China, maintains its primary manufacturing and industrial base in Danyang, Jiangsu Province, and operates an international regional center in Singapore to support overseas market expansion. The company operates through a vertically integrated business model spanning upstream chemical monomer synthesis, specialized lens casting and coating, and downstream frame design and finished eyewear assembly.
The company provides a comprehensive portfolio of optical products and services, categorized into: functional and corrective optical lenses, including adolescent myopia management lenses marketed under the EasyGo and EasyGo Pro series utilizing multi-point defocus ocular axis control technology; ultra-high and high-refractive-index lenses, encompassing 1.60, 1.67, 1.71, and 1.74 index product lines; progressive multifocal lenses for presbyopia correction; anti-fatigue and digital eye-strain relief lenses; blue-light filtering, photochromic, and polarized outdoor sunglass lenses; specialized post-operative and protective lenses; and customized prescription optics; raw optical materials and chemical resin monomers, encompassing proprietary KR resin, KR ultra-tough impact-resistant resin, and PMC ultra-bright high-transmittance resin delivering light transmittance rates up to 98.6 percent; and eyewear accessories and assembly solutions, including optical frames, sunglass frames, precision lens edging, optical laboratory processing, and one-stop prescription eyewear fulfillment services for optical retailers, optometrists, and medical ophthalmology clinics.
In recent developments, Mingyue Optical Lens has executed significant product innovations, commercial partnerships, and strategic expansions across the vision care and wearable technology markets. The company introduced its 1+4+N product strategy to prioritize growth in high-refractive-index 1.74 series lenses, PMC ultra-bright optics, progressive multifocal lenses, and outdoor tinted categories, underscored by the commercial rollout of the EasyGo Light Advantage myopia management lens featuring intelligent contrast calibration technology. In smart hardware, the company established a commercial supply partnership with Xiaomi for optical lenses integrated into smart audio glasses, while actively exploring collaborative development with additional consumer electronics firms in the smart eyewear and augmented reality segments. To deepen its clinical presence, Mingyue Optical Lens expanded collaborative clinical trials and distribution agreements with specialized ophthalmic institutions, including Zhongshan Ophthalmic Center and Aier Eye Hospital Group. Furthermore, the company broadened brand engagement through cross-industry intellectual property licensing partnerships with Universal Pictures, completed a board of directors governance transition in late 2025, and established strategic upstream monomer reserves and alternative sourcing initiatives to secure manufacturing operations against raw material market volatility.